Clinical Trials Directory

Trials / Unknown

UnknownNCT01463553

Improving Primary Spontaneous Pneumothorax (PSP) Treatment Techniques in VATS

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
320 (estimated)
Sponsor
Beijing Haidian Hospital · Academic / Other
Sex
All
Age
10 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to: 1. Evaluate the validity of using abnormal characteristics of the pneumothorax line, as evaluated from chest X-ray film, as the operative indications for video-assisted thoracic surgery (VATS) on primary spontaneous pneumothorax (PSP). 2. Through a randomized double blind controlled trial on patients whose PSP was caused by lung bullae, evaluate the effectiveness of pleurodesis in terms of the rate of recurrence of PSP and the trauma of the operation on patients. 3. Based on the findings, establish selection standards for the timing of surgery to treat PSP by VATS and establish technical specifications for performing operations on different types of lung bullae. The goal is to improve the diagnosis and treatment of PSP so as to reduce the recurrence rate of pneumothorax, reduce the trauma of operation, shorten hospital stays and postoperative recovery time, and provide better services for returning to everyday life and improving the quality of life for patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREVATS pleurodesisBased on the findings, establish selection standards for the timing of surgery to treat PSP by VATS and establish technical specifications for performing operations on different types of lung bullae. The goal is to improve the diagnosis and treatment of PSP so as to reduce the recurrence rate of pneumothorax, reduce the trauma of operation, shorten hospital stays and postoperative recovery time, and provide better services for returning to everyday life and improving the quality of life for patients.

Timeline

Start date
2011-07-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2011-11-02
Last updated
2013-11-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01463553. Inclusion in this directory is not an endorsement.